Alzheimer’s Risk Linked to Prostate Cancer Therapy in Study

Alzheimer’s Risk Linked to Prostate Cancer Therapy in Study
Men undergoing androgen deprivation therapy (ADT) for prostate cancer  could be almost twice as likely to be diagnosed with Alzheimer's disease (AD) than those not treated with ADT. The findings, in a study published in the Journal of Clinical Oncology, also show that the risks of developing Alzheimer's might continue to rise as the duration of ADT treatment lengthens. Analysis, conducted by Penn Medicine and Stanford University researchers, was based on t
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *